| 2.35 -0.04 (-1.67%) | 05-08 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.05 | 1-year : | 3.5 |
| Resists | First : | 2.61 | Second : | 3 |
| Pivot price | 2.4  |
|||
| Supports | First : | 1.99 | Second : | 1.65 |
| MAs | MA(5) : | 2.4 |
MA(20) : | 2.49 |
| MA(100) : | 2.99 |
MA(250) : | 3.28 |
|
| MACD | MACD : | -0.1  |
Signal : | -0.1 |
| %K %D | K(14,3) : | 47.2 |
D(3) : | 46.5 |
| RSI | RSI(14): 45.8 |
|||
| 52-week | High : | 6.78 | Low : | 1.99 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SINT ] has closed above bottom band by 49.4%. Bollinger Bands are 24.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.54 - 2.55 | 2.55 - 2.57 |
| Low: | 2.27 - 2.28 | 2.28 - 2.3 |
| Close: | 2.37 - 2.4 | 2.4 - 2.42 |
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Thu, 07 May 2026
SiNtx Technologies, Inc. - Common Stock (NQ: SINT - FinancialContent
Tue, 14 Apr 2026
Sintx Technologies (SINT) president granted 4,910 common shares as equity award - Stock Titan
Mon, 23 Mar 2026
After its first human foot implant, SINTX shifts to 2026 rollout - Stock Titan
Thu, 19 Mar 2026
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant - Sahm
Wed, 18 Feb 2026
SINTX Technologies appoints Ryan Elmore as president - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 4 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 16.2 (%) |
| Held by Institutions | 7 (%) |
| Shares Short | 200 (K) |
| Shares Short P.Month | 212 (K) |
| EPS | -6.16 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.74 |
| Profit Margin | 0 % |
| Operating Margin | -787.6 % |
| Return on Assets (ttm) | -69.9 % |
| Return on Equity (ttm) | -303.8 % |
| Qtrly Rev. Growth | -46.5 % |
| Gross Profit (p.s.) | 0.11 |
| Sales Per Share | 0.24 |
| EBITDA (p.s.) | -2.49 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -0.39 |
| PEG Ratio | 0 |
| Price to Book value | 3.24 |
| Price to Sales | 9.69 |
| Price to Cash Flow | -1.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|